Bridgewater Associates’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Bridgewater Associates's ATRC Position: Q2 2026 in Review
Bridgewater Associates increased its AtriCure (ATRC) stake by 128% in Q2 2026, buying an estimated $1.2M and bringing the position to 76,307 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #700.
Bridgewater Associates first reported a position in ATRC in Q2 2021 and has held it in 16 quarters since. The position peaked at $4.25M in Q1 2022. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Bridgewater Associates held 76,307 shares of AtriCure worth $2.14M as of Q2 2026.
- Bridgewater Associates bought 42,790 AtriCure shares in Q2 2026, an estimated $1.2M.
- AtriCure made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #700 holding.
- Bridgewater Associates first reported a position in AtriCure in Q2 2021 and has held it in 16 quarters since.
- Bridgewater Associates's AtriCure position peaked at $4.25M in Q1 2022.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.